These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 542674)

  • 21. Cefazedone: microbiological evaluation in comparison with cephalothin and cefazolin.
    Wahlig H; Dingeldein E; Mitsuhashi S; Kawabe H
    Arzneimittelforschung; 1979; 29(2a):369-78. PubMed ID: 582712
    [No Abstract]   [Full Text] [Related]  

  • 22. Beta lactamase resistance of newer cephalosporins and antimicrobial effectiveness against gram-negative bacilli.
    Farrar WE; O'Dell NM
    Infection; 1977; 5(4):224-7. PubMed ID: 413793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinico-microbiologic bases for the use of new cephalosporins].
    De Bac C; Mascellino MT; Nuti M
    Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
    [No Abstract]   [Full Text] [Related]  

  • 24. Methodological implications of testing anaerobe susceptibility to cephalosporins (cefazolin, cefamandole, cefoxitin).
    Krasemann C; Werner H; Hildenbrand G; Benning M; Brandt U; Ungerechts J
    Infection; 1980; 8 Suppl 2():S182-6. PubMed ID: 6969693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro bactericidal action of cefoperazone, cefoxitin, cefuroxime, cefazolin and cephaloridine.
    Piantieri G; Cafarelli A; Magliulo E
    G Batteriol Virol Immunol; 1981; 74(1-6):15-25. PubMed ID: 6458524
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro comparison of cefoxitin, cefamandole, cephalexin, and cephalothin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1976 Jun; 9(6):994-9. PubMed ID: 938029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of resistance to cefamandole: possible role of cefoxitin-inducible beta-lactamases.
    Sanders CC; Sanders WE
    Antimicrob Agents Chemother; 1979 Jun; 15(6):792-7. PubMed ID: 314270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of gentamicin-resistant Enterobacteriaceae to cefamandole and cefoxitin.
    Rosenthal SL; Freundlich LF; Quraishi MA
    Chemotherapy; 1979; 25(3):157-61. PubMed ID: 456076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3 new cephalosporins: cefamandole, cefuroxime, cefoxitin].
    Mirimanoff RO; Héraïef E
    Rev Med Suisse Romande; 1981 Dec; 101(12):963-8. PubMed ID: 7342276
    [No Abstract]   [Full Text] [Related]  

  • 30. The cephalosporins: activity and clinical use.
    Weinstein AJ
    Drugs; 1980 Aug; 20(2):137-54. PubMed ID: 6995096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pH upon the activity of cefoxitin.
    Tobe K; Nishino T; Hirai Y; Nakazawa S
    J Antibiot (Tokyo); 1977 Dec; 30(12):1123-6. PubMed ID: 23373
    [No Abstract]   [Full Text] [Related]  

  • 32. [In vitro sensitivity of hospital-isolated pathogenic bacterial strains to 4 different cephalosporins: cephaloridine, cefotaxime, cefoxitin, cefonicid].
    Rosina M; Mauri J; Germiniani R; Mastropasqua E; Figini G
    Minerva Chir; 1986 Aug; 41(15-16):1347-51. PubMed ID: 3774182
    [No Abstract]   [Full Text] [Related]  

  • 33. [Susceptibility to cefazolin, cefamandole and ceftazidime in Staphylococcus strains].
    Wiktorowicz-Belzyt E; Wojak I; Janicka G
    Med Dosw Mikrobiol; 1997; 49(1-2):35-43. PubMed ID: 9411070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
    Mascellino MT; Prignano G; Iegri F; Lorenzi A
    Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cefamandole- and cefoxitin-produced changes in drug sensitivity of Escherichia coli].
    Jastalska D; Lupicki W; Zapaśnik M; Pajchel G; Chojnowski W
    Pol Tyg Lek; 1988 Dec; 43(49):1576-9. PubMed ID: 3076651
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cooperative study of bacterial incidence and susceptibility to cefamandole and other antibiotics (author's transl)].
    de Vega JC; Pais JR; del Tánago AG
    Med Clin (Barc); 1980 May; 74(10):387-94. PubMed ID: 7412431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of in vitro antimicrobial activity of cefamandole and cefazolin with cephalothin against over 8,000 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jun; 9(6):1066-9. PubMed ID: 938021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P; Gaillard JL
    Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activity of cefotaxime against enterobacteriaceae. Comparison with cephalothin, cefazolin, cefamandole, cefoxitin and cefuroxime on 117 strains isolated from neutropenic patients (author's transl)].
    Tancrede C; Mariel C; Chaigneau H; Eveno J
    Nouv Presse Med; 1981 Feb; 10(8):545-7. PubMed ID: 6259589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of resistance in Staphylococcus aureus and Klebsiella pneumoniae by exposure to cephalothin and cefoxitin.
    Hoeprich PD; Huston AC
    J Infect Dis; 1976 Jun; 133(6):681-5. PubMed ID: 778303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.